Beta-glucan compounds, compositions, and methods

US9943607B2 · kind B2 · utility

Assignee

• BIOTHERA INC. · US

Inventors

• Nandita Bose · Plymouth, US
• Anissa S.H. Chan · Arden Hills, US
• Michael E. Danielson · Windom, US
• Mary A. Antonysamy · Woodbury, US
• John Vasilakos · Woodbury, US
• Keith B. Gorden · Woodbury, US
• Steven Leonardo · Rosemount, US
• William J. Grossman · San Francisco, US

Key dates

• Filing date: May 9, 2012
• Grant date: Apr 17, 2018
• Expiry date: May 6, 2033

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K39/39
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Described herein are beta-glucan compounds, compositions, and methods. Generally, the methods exploit the observation that beta-glucan compounds can bind to B cells. Thus, the methods generally include administering a beta-glucan compound to a subject in an amount effective for the beta-glucan compound to bind to a B cell and modulate at least one biological function of the B cell.